EIF2AK1 and type 1 diabetes mellitus: A final limitation is that our studies do not directly address whether and how other ISR kinases (PKR, GCN2, HRI) might contribute to T1D development and whether additional inhibition of these other kinases might potentiate the responses we observed and thereby more completely prevent disease.